RCUS in the 13F filings
Arcus Biosciences Inc · CUSIP 03969F109
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 20,012,776
- combined, among listed positions
- Reported value
- $433m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 18 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -255,343.
Managers listing RCUS in Q1 2026
25 of 25 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 1,329,935 shares now+1,225,234
- Wellington Management Group LLPexisting position · 6,089,516 shares now+905,007
- Invesco Ltdexisting position · 820,820 shares now+406,455
- Renaissance Technologies LLCexisting position · 424,700 shares now+392,000
- Marshall Wace LLPexisting position · 3,761,437 shares now+373,643
Reductions
- Point72 Asset Management LPexisting position · 129,273 shares now-3,150,727
- Susquehanna International Group LLPexisting position · 143,371 shares now-198,494
- Winton Group Ltdexisting position · 32,820 shares now-29,431
- AllianceBernstein LPexisting position · 124,085 shares now-9,013
- MFS Investment Managementexisting position · 22,617 shares now-599
New positions and exits
New (3)
Exited (4)
- Balyasny Asset Management LLCwas $19m
- Millennium Management LLCwas $4.0m
- Verition Fund Management LLCwas $502k
- Walleye Capital LLCwas $0
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $716k | n.a. | n.a. |
| Q2 2019 | 1 | $133k | n.a. | n.a. |
| Q3 2019 | 1 | $210k | n.a. | n.a. |
| Q1 2020 | 2 | $5.2m | n.a. | n.a. |
| Q2 2020 | 8 | $51m | n.a. | n.a. |
| Q3 2020 | 4 | $12m | n.a. | n.a. |
| Q4 2020 | 2 | $14m | n.a. | n.a. |
| Q1 2021 | 2 | $48m | n.a. | n.a. |
| Q2 2021 | 2 | $48m | n.a. | n.a. |
| Q3 2021 | 1 | $59m | n.a. | n.a. |
| Q4 2021 | 3 | $81m | n.a. | n.a. |
| Q1 2022 | 1 | $8.3m | n.a. | n.a. |
| Q2 2022 | 1 | $3.8m | n.a. | n.a. |
| Q3 2022 | 1 | $1.5m | n.a. | n.a. |
| Q4 2022 | 2 | $26m | n.a. | n.a. |
| Q1 2023 | 5 | $28m | n.a. | n.a. |
| Q2 2023 | 6 | $69m | n.a. | n.a. |
| Q3 2023 | 2 | $23m | n.a. | n.a. |
| Q4 2023 | 4 | $27m | 2 | 1 |
| Q1 2024 | 5 | $97m | 4 | 1 |
| Q2 2024 | 4 | $95m | 2 | 2 |
| Q3 2024 | 5 | $103m | 4 | 1 |
| Q4 2024 | 4 | $85m | 3 | 1 |
| Q1 2025 | 4 | $64m | 3 | 1 |
| Q2 2025 | 3 | $84m | 2 | 1 |
| Q3 2025 | 4 | $117m | 1 | 3 |
| Q4 2025 | 6 | $265m | 12 | 18 |
| Q1 2026 | 5 | $310m | 18 | 9 |
| Q2 2026 | 5 | $346m | 13 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RCUS and LLY →RCUS and JNJ →RCUS and VRTX →Choose a stock to compare with RCUS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RCUS, latest filings →Back to the 13F Explorer →